Biggest News Aggregation in the World
📰 Temporary Use Authorization News

Temporary Use Authorization News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Temporary Use Authorization. Real-time updates on events, politics, business and more.

ABIONYX Pharma Initiates Discussions With IRIS Pharma, a World Leader in Preclinical and Clinical Ophthalmology Research, With a View to a Possible Strategic Deal

Regulatory News: ABIONYX Pharma (Paris:ABNX) (FR0012616852 ABNX PEA PME eligible), a next-generation biotech company dedicated to the discovery and development of innovative therapies, announced
Arthur Rouill Louis Victor Delouvrier Regulatory News Temporary Use Authorization Victor Delouvrier

ABIONYX Pharma Announces Positive Preclinical Results in a Model of Uveitis and Launches the Strategic Development of the First Class of Biomedicines in Ophthalmology Based on its bio-HDL

Positive preclinical results in a model of uveitis Development of the first class of biomedicines in ophthalmology with bio-HDL Regulatory News: ABIONYX Pharma (Paris:ABNX) (FR0012616852
United States France General Catherine Creuzot Garcher Louis Victor Delouvrier Nicolas Merigeau Christophe Baudouin

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science